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The increasing role of hair analysis in forensic toxicological investigations principally owes to 
recent improvements of mass spectrometric instrumentation. Research achievements during the last 
six years in this distinctive application area of analytical toxicology are reviewed. The earlier state 
of the art of hair analysis was comprehensively covered by a dedicated book (Kintz, 2007a), that 
represents key reference of the present overview. Whereas the traditional organization of analytical 
methods in forensic toxicology divided target substances into quite homogeneous groups of drugs, 
with similar structures and chemical properties, the current approach often takes advantage of the 
rapid expansion of multiclass and multiresidue analytical procedures; the latter is made possible by 
the fast operation and extreme sensitivity of modern mass spectrometers. This change in the 
strategy of toxicological analysis is reflected in the presentation of the recent literature material, 
which is mostly based on a fit-for-purpose logic. Thus, general screening of unknown substances is 
applied in diverse forensic contexts than drugs of abuse testing, and different instrumentation (triple 
quadrupoles, time-of-flight analyzers, linear and orbital traps) is utilized to optimally cope with the 
scope. Other key issues of modern toxicology, such as cost reduction and high sample throughput, 
are discussed with reference to procedural and instrumental alternatives. 
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I.  INTRODUCTION 1 
 2 
The analysis of biological specimens to detect of various types of drugs is consistently requested 3 
within forensic investigations as a necessary step to prove exposure to these substances. Although 4 
blood and urine remain the matrices of choice to detect recent exposure, hair analysis is gaining 5 
ever-increasing importance, as its potentials, limitations, and new application areas are 6 
progressively uncovered. Although, for most drugs, any evidence of exposure is erased from blood 7 
and urine a few days (or hours) after their intake because of the natural metabolic and excretion 8 
body processes, a minute portion of the same drugs and metabolites is ultimately incorporated 9 
through several routes (blood capillaries, sweat, and sebum) into the keratin structure of the hair, 10 
from which it is hardly removed. This drug-fixing into the hair structure resists hair growth for 11 
several months and leads to a potential chronological trace of drug exposure, with farther periods 12 
corresponding to the hair segments more distant from the hair root. The continuous improvement of 13 
analytical procedures and instrumental technologies allows one to determine the very small amounts 14 
of drugs included into the hair at ever-decreasing concentrations, insomuch as there are currently 15 
several scientific reporting of drug detection in hair after a single exposure. Progresses in 16 
chromatographic and mass spectrometric techniques have both equally contributed to the 17 
impressive results achievable nowadays with modern forensic toxicology in hair analysis. 18 
On the negative side of hair analysis, there are several potential sources of bias that should 19 
always be taken into account in order to produce reliable conclusions from experimental results. 20 
First of all, hair is not a homogeneous matrix; thus, careful and representative hair sampling is a 21 
necessary prerequisite of correct analysis. Secondly, the degree of hair incorporation depends on the 22 
chemical structure and related properties of the drug, including melanin affinity, lipophilicity and 23 
membrane permeability (Kintz, 2012a). Third, adsorption of external substances from the 24 
environment is occasionally claimed as a source of false-positive results, especially for 25 
professionally-exposed subjects and volatile substances, such as, for example, cocaine (LeBeau & 26 
Montgomery, 2009). To prevent this inconvenience, preliminary washing of hair samples is always 27 
recommended to eliminate any possible interfering substances adsorbed onto the external surface of 28 
the hair. Segmental analysis and acceptance of cut-off values often rule out the chance that 29 
exogenous drug sources might have contaminated the internal keratin structure. Forth, strong 30 
cosmetic hair treatments, such as the use of oxidants or highly basic coloring, might damage the 31 
keratin structure to favor release of incorporated substances to finally lead to false-negative results. 32 
Also, repeated shampooing might partly wash out the hydrophilic drugs incorporated into the hair. 33 
 3 
Lastly, the use of cosmetic products such as grease, sprays, and gels might also interfere with hair 34 
analysis. 35 
A comprehensive review of drug testing in hair was published in a dedicated book edited by 36 
Pascal Kintz (2007a). Since then, only one review was published on abused drug analysis in hair 37 
samples, in which chapters are organized on the basis of the various classes of substances (Wada et 38 
al., 2010). The present review updates Kintz’s book, under the perspective of its chapters 10-15 39 
(Kintz, 2007a); namely, under application areas point of view. The studies published before 2006 40 
are only incidentally cited in the present review, whereas extensive coverage of the papers 41 
published in the last six years is presented. 42 
 43 
II.  APPLICATION AREAS OF MASS SPECTROMETRY TO HAIR 44 
ANALYSIS IN FORENSIC TOXICOLOGY 45 
 46 
A. Targeted Drug Screening for Specific Drug Classes 47 
Although screening of psychoactive substances in biological specimens might have a variety of 48 
objectives, in terms of target chemical classes and purposes of control, legislation of most countries 49 
make a clear distinction between drugs of abuse, whose use is prohibited in almost all 50 
circumstances, and pharmaceutical substances, whose use is permitted under medical control and 51 
prescription, even though they are occasionally abused. Most routine screening, such as, for 52 
example, workplace testing, are addressed to the drugs of abuse only, whereas other psychoactive 53 
pharmaceuticals are searched in selected subjects and follow anamnestic indications. In particular, 54 
detection of the most-common drugs of abuse in hair samples (Kintz, 2007a; Kintz et al., 2006; 55 
Pragst & Balikova, 2006; Wada et al., 2010) is increasingly requested for the retrospective 56 
withdrawal control of habitual drug abusers, as well as in other toxicological investigations, such as 57 
workplace drug testing [EWDTS (European Workplace Drug Testing Society), 2010; Caplan & 58 
Goldberger, 2001], driving re-licensing, occasional or pre-natal exposure to drugs (Kintz, 2007b; 59 
Falcon et al., 2012), and post-mortem toxicology. Therefore, although hair samples are routinely 60 
collected and analyzed in forensic and toxicological laboratories, most published methods were 61 
implemented to determine class-specific groups of compounds, mainly cannabinoids, 62 
amphetamines, cocaine, and opiates, even though the analytical procedures have been constantly 63 
updated (Kintz, 2007a; Pragst & Balikova, 2006; Wada et al., 2010). 64 
 65 
 4 
1. Classes of drugs 66 
 67 
Although the widespread abuse of hashish or marijuana makes the detection of long-term 68 
exposure to ∆9-tetrahydrocannabinol (THC) by hair analysis extremely important in clinical and 69 
forensic contexts, drug inhalation and adsorption from environmental smoke are frequently claimed 70 
to justify positive detection of THC and/or its main metabolite. Although a cut-off of 0.1 ng/mg was 71 
traditionally recommended, more recently a cut-off of 0.05 ng/mg has been proposed as a suitable 72 
level to detect also occasional users (Pragst & Nadulski, 2005) and for confirmation analyses 73 
(Cooper et al., 2012). 74 
GC/MS is the technique of choice for THC detection in the majority of published methods, and 75 
no particular analytical improvement has been proposed recently, except for the increasing role 76 
played by headspace solid-phase microextraction (HS-SPME) procedures. Nadulski and Pragst 77 
developed, validated, and routinely applied to driving-ability examination a new method for 78 
cannabidiol (CBD) and cannabinol (CBN) with improved sensitivity (Nadulski & Pragst, 2007). 79 
The authors used alkaline digestion of 15-30 mg hair aliquots, subsequent liquid-liquid extraction 80 
(LLE), automated HS-SPME after in-sample silylation, and GC/MS-SIM (selected ion monitoring) 81 
analysis. For THC, a limit of detection (LOD) of 0.012 ng/mg was obtained. A similar procedure 82 
without derivatization with 10 mg of hair sample was proposed (Rodrigues de Oliveira et al., 2007), 83 
but the reported LOD and LOQ (limit of quantification) values of 0.07 ng/mg and 0.12 ng/mg, 84 
respectively, are above the recommended cut-off limits and make the method apparently not 85 
appropriate for routine analysis. Emídio et al. developed and validated a method for the 86 
determination of THC, CBD, and CBN in hair samples, with HS-SPME combined with GC/MS/MS 87 
(ion trap) detection (Emídio et al., 2010). From a 10 mg hair sample, an LOD of 0.031 ng/mg and 88 
LOQ of 0.062 ng/mg were obtained; the latter was slightly higher than the cut-off value of 0.05 89 
ng/mg. Nonetheless, from 10 hair samples from cannabis users, an average concentration of 0.056 90 
ng/mg was found; i.e., below the reported LOQ. 91 
Unlike THC, the improvement of existing analytical methods for stimulants, including cocaine 92 
and amphetamines, in hair samples has been widely investigated recently. Lee et al. used a standard 93 
GC/MS procedure, after derivatization with trifluoroacetic anhydride, in order to study the 94 
abundance ratio of methamphetamine (MA) and its metabolite amphetamine (AP) in hair and hence 95 
aid the positive results interpretation (Lee et al., 2009). High MA concentrations, together with low 96 
AP percentage, were related to severe and chronic drug abuse (Lee et al., 2009). In order to 97 
facilitate MA and AP analysis in hair, Miyaguchi et al. developed a simple and fast (1 hour) method 98 
for sample preparation named MiAMi (micropulverized extraction-acqueous acetylation-99 
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microextraction by packed sorbent) followed by GC/MS (Miyaguchi et al., 2009). The amount of 100 
hair sample required for qualitative analysis based on full-scan mass spectra was only 5 mg, 101 
whereas 1 mg of a hair specimen was sufficient for amphetamine quantitation. The same group 102 
(Miyaguchi et al., 2007) previously published an extraction method on micropulverized hair for the 103 
HPLC-MS/MS determination of MA and AP, in which only 2 mg of sample were used. 104 
An LC-MS/MS method that used electrospray ionization (ESI) and a triple quadrupole 105 
instrument was developed and validated by Chèze et al. to determine AP, MA, 3,4-106 
methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”), 107 
3,4-methylenedioxyethamphetamine (MDEA), and N-methyl-1-(3,4-methylenedioxyphenyl)-2-108 
butanamine (MBDB) at low concentration levels, in hair, blood, and urine (Chèze et al., 2007). 109 
With 20 mg of decontaminated hair, the experimental LODs ranged from 0.3 pg/mg for MBDB to 110 
6.3 pg/mg for MDA, where the recommended cut-off limit for amphetamines is 200 pg/mg (Cooper 111 
et al., 2012). The same study reported a real forensic case, in which the high sensitivity of the LC-112 
ESI-MS/MS method was exploited to detect MDMA in a hair sample, after a single oral dose 113 
administration to an unaware victim (Chèze et al., 2007). Another recent study reported the 114 
development of an LC-MS/MS method for the simultaneous determination of a large set of 115 
amphetamine-like anorectics and their metabolites in hair samples (Lee et. al., 2012). The procedure 116 
was used to analyze the diffusion of anorectics abuse in Korea. The hair incorporation of MA and 117 
AP following controlled administration of MA to seven volunteers was recently studied (Polettini et 118 
al., 2012). For these amphetamines, significant dependence (i.e.; linear direct correlation) of drug 119 
incorporation on hair melanin content was clearly demonstrated. 120 
Besides MALDI-imaging techniques, several traditional methods were recently proposed to 121 
determine the most common stimulant drug (i.e., cocaine) in hair samples. The suggested cut-off 122 
concentration is 500 pg/mg for cocaine and 50 pg/mg for its main metabolite, benzoylecgonine 123 
(BZE) (Cooper et al., 2012). A GC/MS analytical method to quantify cocaine and its main 124 
metabolite BZE in hair samples was proposed (Barroso et al., 2008). Despite the simple 125 
instrumentation utilized, the method proved to be sensitive and specific, and allowed one to detect 126 
20 and 15 pg/mg of cocaine and BZE, respectively, from only 20 mg of sample. 127 
Improved sensitivities were obtained with LC-MS/MS methods. Moore et al. developed and 128 
validated an LC-MS/MS procedure for the analysis of cocaine and its metabolites (BZE, 129 
cocaethylene, and norcocaine) in hair with an atmospheric pressure chemical ionization (APCI) 130 
source and a triple quadrupole (QqQ) mass analyzer (Moore et al., 2007). For all analytes, the 131 
LOQs (50 pg/mg) and LODs (25 pg/mg) made the method suitable for routine forensic analysis. 132 
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A simple and fully validated procedure for the qualitative and quantitative determination of 133 
opiates in hair was presented (Barroso et al., 2010a). This paper describes a GC/MS method for the 134 
analysis of codeine, morphine, 6-monoacetylmorphine (6-MAM), 6-acetylcodeine, and tramadol in 135 
20 mg hair samples. The presence of the screened analytes was demonstrated in several real cases, 136 
among which it was proven that tramadol is occasionally abused by opiate addicts. A combination 137 
of opiates, cocaine and metabolites was simultaneously screened with an LC-ESI-MS/MS method 138 
(Huang et al., 2009). This method was fully validated and used in the analysis of 79 authentic hair 139 
samples, and demonstrated that a multiresidue approach might screen different classes of drugs at 140 
the same time. 141 
The objective of cost reduction of workplace drug screening with a multiresidue UHPLC-142 
MS/MS strategy was explicitly cited in a recent study (Di Corcia et al., 2012). Thirteen analytes, 143 
including opiates, cocaine, amphetamines, THC, buprenorphine, methadone, and a few metabolites, 144 
were simultaneously screened in hair samples. A simple sample preparation combined with 145 
multiclass analysis and fast chromatographic separation allowed one to obtain high sample 146 
throughput, together with excellent sensitivity and selectivity; the procedure is valuable for large 147 
sample workload and reduced costs of analysis (Di Corcia et al., 2012). 148 
 149 
2. New instrumental set-up 150 
 151 
A new and original study, aimed to the direct detection of MA in hair samples, used imaging 152 
mass spectrometry (IMS) to perform micro-segmental analysis (Miki et al., 2011). In practice, a hair 153 
shaft was affixed to a carbon tape and manually cut lengthwise to produce micro-incisions at 154 
extremely close range with a razor and a microscope. After matrix deposition, IMS was obtained by 155 
matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) and MALDI-Fourier 156 
transform ion cyclotron resonance (FTICR) mass spectrometers. IMS produced a barcode-like 157 
image of methamphetamine on the longitudinal sections of the hair shafts, obtained from a 158 
methamphetamine chronic abuser, to indicate the periods and sequence of single MA intake (Miki 159 
et al., 2011). This innovative approach appears to be very promising in the forensic context, as soon 160 
as the hair sample preparation can be automated. 161 
A MALDI hybrid triple quadrupole linear ion trap (QqQLIT) instrument, equipped with a high 162 
repetition rate laser, was recently proposed to perform MS imaging on a single hair, for cocaine 163 
consumption monitoring (Porta et al., 2011). The QqQLIT technology was exploited to 164 
simultaneously achieve target quantification with selected reaction monitoring (SRM) mode of 165 
operation and sensitive MS3 acquisition for confirmatory analysis. MS imaging of intact single hair 166 
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sample offers much higher resolution than segmental LC-MS/MS analysis, and only depends on the 167 
distance between two adjacent laser shots. However, the minimal 0.1 mm resolution allowed by the 168 
laser and corresponding to a theoretical average hair growth of less than 12 h, has currently little 169 
significance in forensic investigations, beacuse the complex nature of keratin incorporation 170 
mechanisms and the heterogeneous physiology of hair growth might provide a much larger bias on 171 
chronological assessment. Single washed hair samples were fixed onto a stainless steel MALDI 172 
plate with a double-sided adhesive foil, and the MALDI matrix was manually sprayed. First, an 173 
imaging profile of cocaine and metabolites was acquired in the SRM mode over the whole hair 174 
length, taking into account that highly selective transitions should be chosen to compensate for the 175 
absence of chromatographic separation. Secondly, MS/MS and MS3 experiments were performed 176 
for confirmatory identification. The entire analytical workflow is represented in Figure 1 (Porta et 177 
al., 2011). An experimental LOD of 5 ng/mg allows for cocaine detection in the hair of chronic 178 
abusers, but not after a single administration. Moreover, scaling down to single-hair analysis makes 179 
the choice of representative sampling crucial, unless a further source of uncertainty and bias is 180 
introduced. 181 
In order to detect all cocaine metabolites, including the highly polar ecgonine methyl ester 182 
(EME), Quintela et al. developed and validated a hydrophilic interaction liquid chromatography 183 
(HILIC) method to be coupled to tandem mass spectrometry (Quintela et al., 2010). With as little as 184 
10 mg of specimen, experimental LODs were better than or equal to 1 pg/mg. The recognition of 185 
ultra-trace amounts, at low pg/mg of hair, appears to be crucial for EME detection, because this 186 
metabolite has a very low incorporation rate into the hair shaft (Quintela et al., 2010). Recently, 187 
Thibert et al. adopted a clean-up process for hair extracts based on molecularly imprinted polymers 188 
(MIP) selective for cocaine and BZE, followed by LC-MS/MS analysis (Thibert et al., 2012). An 189 
LOD lower than 70 pg/mg was reached for both molecules, slightly above the suggested cut-off 190 
value for BZE (Cooper et al., 2012). 191 
A fast, but only qualitative, screening method to detect cocaine and its metabolites from hair 192 
samples used MALDI-TOF technology (Vogliardi et al., 2009). The whole hair sample preparation 193 
for MALDI analysis turned out to be significantly more rapid and simpler than for GC/MS, and data 194 
acquisition in MALDI analysis is, in turn, much quicker than in GC/MS. Thus, the MALDI 195 
technique shows clear advantages over the traditional approach, when fast screening of a large 196 
number of sample is required, as the same authors subsequently demonstrated by validating and 197 
testing the new method on 304 real hair samples (Vogliardi et al., 2010). High throughput and fit-198 
for-purpose principles both find neat application in this well-designed example of fast cocaine 199 
screening in hair samples. 200 
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 201 
B. Non-Targeted Drug Screening 202 
Most of the methods cited in the preceding chapter are specific for a class of drugs. The highly-203 
focused objective of these analytical investigations allows one to optimize sample treatment, clean-204 
up, and chromatographic conditions in order to maximize recoveries and to meet the acceptance 205 
criteria of sensitivity and specificity that lead to accurate quantification for confirmation. However, 206 
their applicability in general drug screening for acute intoxication and autopsic analysis appears 207 
limited. In practice, these class-specific procedures find useful application when the target analytes 208 
can be predicted in advance; for example, in heroin overdose fatalities. 209 
In the daily activity of forensic laboratories, it is quite frequent that the target analytes cannot be 210 
foreseen, so that a wide range or "general" screening of abused drugs is commonly required, as it 211 
occurs in most acute intoxications and post-mortem investigations. Whenever a multitude of 212 
candidate substances might represent the cause of intoxication or death, several analytical 213 
procedures are likely to be used on the collected biological specimen, with a direct impact on time, 214 
costs, and efficiency. For this reason, comprehensive screening procedures of multiclass drugs are 215 
progressively introduced into the analytical practice, even if the method conditions should 216 
compromise on absolute performances, in terms of recovery, sensitivity, selectivity, and accuracy, 217 
due to the presence of target analytes with widely different physico-chemical properties. 218 
Even though hair is not the preferred biological matrix to ascertain acute intoxication, hair 219 
analysis is frequently commissioned to complete the circumstantial evidences; i.e., to ascertain 220 
whether the victim formerly abused drugs or whether any drug was administered to him/her earlier. 221 
To meet the high demand for drug screening in hair samples, toxicology laboratories are forced to 222 
update their procedures in order to target an ever-increasing number of drugs, but also to achieve 223 
rapid, simple, and sensitive testing with reduced sample preparation and fast instrumental 224 
processing so as to increase the overall sample throughput. 225 
 226 
1. Methods based on GC separation 227 
 228 
Cordero and Paterson developed and validated a GC/MS protocol to simultaneously quantify 229 
fourteen compounds, including some amphetamines, opiates, cocaine and metabolites, diazepam, 230 
and metabolite (Cordero & Paterson, 2007). A two-step derivatization with N-methyl-bis 231 
trifluoroacetamide (MBTFA) and N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA) + 1% 232 
trimethylchlorosilane (TMCS) was used. Due to the general availability of GC/MS instrumentation 233 
in toxicology laboratories and the good analytical performances obtained in this study, this method 234 
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might find useful application in a variety of clinical and forensic investigations. An interesting 235 
evolution of the preceding method was developed by Aleksa et al., that used an HS-SPME-GC/MS 236 
to improve the protocol sensitivity (Aleksa et al., 2012). Seventeen drugs of abuse, including 237 
opiates, cocaine, amphetamines, and opioids, were reacted with the same derivatizing agents 238 
described above, and were detected at LOD levels of 130-200 pg/mg. The method was validated 239 
with only 5-10 mg of hair, and was especially useful for newborn, when sample availability is 240 
limited. Among the wide screening protocols to detect common panels of abused drugs, only few 241 
comprehensive methods include THC, regardless of the instrumental technique used. Merola et al. 242 
developed a new procedure with HS-SPME and GC/MS to provide concomitant determination of 243 
several drugs of abuse, including THC, but not opiates (Merola et al., 2010). A different approach 244 
and derivatizing agent, namely heptafluorobutyric anhydride (HFBA), was used (Wu et al., 2008a) 245 
to develop a GC/MS method for the simultaneous determination of amphetamines, opiates, 246 
ketamine, and their metabolites at LODs of 30-80 pg/mg. The same group (Wu et al., 2008b) 247 
improved selectivity and sensitivity to reach the low pg/mg level with electron capture negative 248 
chemical ionization (NCI) to detect the same derivatives. 249 
TOF mass analyzers have also been used for broad drug screening in hair samples that take 250 
advantage of their full-scan and high-resolution capabilities. In an original study, Guthery et al. 251 
developed a GC×GC-TOF-MS procedure to provide a comprehensive qualitative drug screening of 252 
hair samples (Guthery et al., 2010). The hair extracts were subjected to derivatization with N-253 
methyl-N-(tert-butyldimethyl)trifluoroacetamide (MTBSTFA), which efficiently reacted with a 254 
broad range of multiclass analytes, including opiates, opioids, cocainics, and benzodiazepines. The 255 
2D chromatographic plot obtained from GC×GC separation offers an extremely clear depiction of 256 
the drug content profile, as Figure 2 demonstrates (Guthery et al., 2010). 257 
 258 
2. Methods based on LC separation 259 
 260 
Although the latter GC/MS methods proved suitable to test simultaneously several classes of 261 
drugs of abuse, the need to further expand the assortment of target substances within the same 262 
protocol, without the necessity of derivatization, made the highly flexible LC-MS/MS approach to 263 
multiclass screening more profitable and more widely used than GC/MS. An LC-APCI-MS/MS 264 
method was developed, validated, and applied for the retrospective multi-parameter evaluation and 265 
distribution of eleven drugs of abuse in hair samples (Klis et al., 2007). Subsequently, ESI was 266 
more extensively utilized than APCI, as in a validated LC-MS/MS method (Miller et al., 2008) that 267 
was aimed at the simultaneous quantification of amphetamines, opiates, cocaine and metabolites, 268 
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and diazepam and metabolites (17 compounds) in post-mortem hair samples. The use of an ion trap 269 
mass spectrometer was suggested (Bucelli et al., 2009) to screen 16 drugs of abuse in human hair. 270 
Despite the flexibility of ion traps to provide an easy switch between full-scan and MS/MS or MSn 271 
modes of data acquisition, the method was not expected to provide accurate quantitative 272 
determinations, and needs further validation and a more extended panel before it might find 273 
widespread application in forensic laboratories. Di Corcia et al. proposed a simple sample 274 
extraction and direct injection into a UHPLC-MS/MS system to avoid solid-phase and liquid-liquid 275 
extraction and to achieve fast and simultaneous detection of the most common drugs of abuse, 276 
including THC, in hair samples (Di Corcia et al., 2012) . Lendoiro et al. developed and validated an 277 
LC-MS/MS multiclass screening method for the simultaneous detection of 35 substances, including 278 
THC, and the other most common drugs of abuse (opiates, amphetamines, cocaine, LSD, ketamine 279 
and scopolamine) and pharmaceuticals (benzodiazepines, antidepressants and hypnotics) (Lendoiro 280 
et al., 2012). For the entire range of investigated molecules, LODs were 0.2-50 pg/mg and achieved 281 
better cut-offs than Society of Hair Testing (SOHT) recommendations. In the screening mode of 282 
operation, only one SRM transition per compound was used, but the same procedure could be 283 
transformed into a confirmation method with addition of further target-specific SRM transitions 284 
(Lendoiro et al., 2012). Confirmatory analysis of ketamine and norketamine was the objective of a 285 
recent study that used molecularly imprinted solid-phase microextraction (MISPE) followed by LC-286 
MS/MS (Harun et al., 2010).  287 
An effective method to check for the presence of a wide set of drugs in hair samples was 288 
proposed (Nielsen et al., 2010), to validate an analytical method for the simultaneous screening and 289 
quantification of 52 common drugs and pharmaceuticals in hair with the novel UHPLC-TOF-MS 290 
technology. The panel of compounds was very broad because it included common drugs of abuse, 291 
benzodiazepines, analgesics, antidepressants and antipsychotics. The authors underlined, however, 292 
that the TOF instrument was less useful than a triple quadrupole on low-mass molecules, such as 293 
amphetamines, due to the presence of high background noise and the consequent lack of sensitivity 294 
and linearity (Nielsen et al., 2010). Similar broad drug screening, based on accurate mass 295 
measurements with LC-TOF-MS, was also achieved (Pelander et al., 2008). Also in this study, the 296 
potential to conduct a comprehensive screen (35 targeted analytes) was clearly demonstrated; 297 
however, the authors recommended more-specific instrumentation for target confirmation analyses. 298 
More recently, an automated screening method for the simultaneous identification and quantitation 299 
of 30 compounds (including most drugs of abuse, but also a few anabolic steroids, β-agonists and 300 
other pharmaceuticals) in hair samples was proposed with fast LC-TOF-MS (Domínguez-Romero 301 
et al., 2011). Progressive instrumental upgrading and method refinement provided improved 302 
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sensitivity with TOF mass spectrometers to allow the detection of the target compounds in the low 303 
pg/mg range (LODs ranged from 5 pg/mg to 50 pg/mg). 304 
General screening of unknown drugs in hair samples was performed with LC combined with a 305 
quadrupole time-of-flight mass spectrometer (LC–QTOF-MS) (Broecker et al., 2012). Systematic 306 
collection of CID (collision-induced dissociation) spectra from quadrupole-selected protonated 307 
molecule used a data-dependent acquisition mode to create a wide dataset to allow the retrospective 308 
investigation of potentially toxic substances present in the hair sample. These CID spectra were 309 
compared with an accurate-mass CID spectral library created by the authors that contained more 310 
than 2500 toxicologically relevant substances (Broecker et al., 2011; Niessen, 2011). For 24 tested 311 
illegal drugs and benzodiazepines, significantly low LODs (3-15 pg/mg) were observed. The 312 
method was applied to hair samples from 90 death cases to reveal 212 substances altogether, even if 313 
only partial agreement with the positive identifications from urine and blood analysis was found, 314 
with many unexpected drugs detected and many reported drugs not detected in hair (Broecker et al., 315 
2012). A similar approach was also applied to hair samples (Liu et al., 2010) with an in-house 316 
spectral library of about 800 substances for the identification of unknown drugs. In this case, the 317 
hybrid QqQLIT mass spectrometer produced low-resolution CID spectra from mass-selected 318 
precursor ions, with good sensitivity provided by the ion-accumulation capability of ion trap. 319 
 320 
3. Other methods 321 
 322 
Besides GC and LC, capillary electrophoretic methods were also occasionally used to separate 323 
drugs extracted from hair samples and to introduce them into the mass spectrometer. Capillary zone 324 
electrophoresis was combined with TOF analysis (CZE-TOF-MS) to detect four amphetamines, 325 
ephedrine, opiates, cocaine, and metabolites in hair samples. The method proved suitable for 326 
qualitative screening of all drugs below the prescribed cut-off limits, but was not fully satisfactory 327 
for accurate quantification, possibly due to the lack of deuterated internal standards (Gottardo et al., 328 
2007; Gottardo et al., 2012). Also, another method, cation-selective exhaustive injection and 329 
sweeping micellar electrokinetic chromatography, proved compliant with the cut-off values in hair 330 
(Lin et al., 2007); however this method and the preceding study represented isolated proposals with 331 
no further application in common laboratory practice. 332 
Quite uniquely, Jackson et al. proposed to eliminate the chromatographic separation with an 333 
ambient ionization technique, defined as low temperature plasma (LTP) ionization, to analyze 334 
biological specimens, including urine, saliva, and hair extracts (Jackson et al., 2010). The method 335 
was tested on 14 drugs that belonged to different classes (amphetamine, BZE, cannabidiol, caffeine, 336 
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cocaine, codeine, diazepam, ephedrine hydrochloride, heroin, ketamine, methadone, 337 
methamphetamine, morphine, and THC) with a linear ion trap mass spectrometer in the positive-ion 338 
mode. However, LOD values were rather high [ng/mL (i.e., 10 ng/mL) to the mg/mL 339 
concentrations] and only one real hair sample was analyzed that showed the presence of cocaine. 340 
The main focus of the study was on the potential of LTP ionization and its compatibility with 341 
miniaturized and portable instrumentation for on-site screening analysis. 342 
 343 
C. Rape Drug Detection and Segmental Analysis 344 
Drug-facilitated crime (DFC) is a general term that involves the administration of a drug to 345 
perpetrate a variety of crimes, including rape or other sexual assault, robbery, money extortion, as 346 
well as the deliberate maltreatment of elderly persons or children under the influence of 347 
psychotropic substances [UNODC (United Nations Office on Drug and Crime), 2011]. In most 348 
DFCs, the victims are subjected to violence or nonconsensual acts while they are incapacitated by 349 
the effects of a drug, often unknowingly ingested. Psychoactive substances used in DFCs might 350 
alter the victim’s degree of consciousness, state of awareness, judgment, and memory. Such 351 
substances can make the victim vulnerable and unable to fight off the attacker, or are used to sedate 352 
the victim in order to facilitate his/her transport by the perpetrator. The drugs used for these 353 
criminal purposes include benzodiazepines, hypnotics, sedatives and anesthetics, drugs of abuse 354 
(such as cannabis, ecstasy, LSD, or heroin), miscellaneous drugs (e.g., scopolamine), and, most 355 
frequently, ethanol (Kintz, 2007b). The ideal substance to be dispensed to perpetrate a crime is the 356 
one that is readily available, easy to administer, able to rapidly impair consciousness, and produce 357 
anterograde amnesia (LeBeau & Montgomery, 2010). 358 
Among DFCs, a drug-facilitated sexual assault (DFSA) occurs when a person is subjected to 359 
unwilling sexual acts while incapacitated or unconscious, due to the effects of ethanol, drugs, and/or 360 
other intoxicating substances (generally called “rape drugs”). It is highly unlikely that the specific 361 
drug used in a DFSA could be determined only by symptoms because the depressant effects of most 362 
of these drugs are similar. This factor makes crucial identification of the administered drug in the 363 
victim’s biological specimen (Negrusz & Gaensslen, 2003). It is well-known that sexual assaults are 364 
significantly under- and late-reported. Evidently, any delay to report a DFSA implies that the 365 
victim’s biological fluids (i.e., blood and urine) are not timely collected, hence rendering more 366 
difficult the toxicologists’ task to identify the incapacitating agent (LeBeau & Mozayani, 2001). 367 
Whenever the natural metabolic processes have eliminated the drug from biological fluids 368 
(typically, urine and blood), hair is the most helpful specimen to be investigated (Negrusz et al., 369 
2000; Villain et al., 2004; Negrusz et al., 2001; Scott, 2009; Parkin & Brailsford, 2009). 370 
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Toxicology laboratories are frequently asked to analyze hair from victims in order to reveal 371 
allegedly administered drugs. Further information is furnished by segmental analysis to generally 372 
provide chronological setting. Head hair should be collected at least four weeks after the alleged 373 
assault [UNODC (United Nations Office on Drug and Crime), 2011]. Since the average growth rate 374 
of human scalp hair is about 1 cm/month, administration of a single dose can be confirmed by drug 375 
detection in the corresponding segment, with no presence in the preceding and subsequent 376 
segments. The expected concentration in hair is generally in the low pg/mg range for most drugs 377 
(Kintz, 2007b; Villain et al., 2005). Therefore, the use of highly sensitive instrumental techniques is 378 
mandatory in the investigation of DFCs (Kintz et al., 2005; Chèze et al., 2005). 379 
 380 
1. Methods based on LC-MS/MS with triple quadrupoles 381 
 382 
The analytical strategy generally starts with a comprehensive screening for benzodiazepines and 383 
other drugs commonly involved in DFCs (Parkin & Brailsford, 2009). In recent years, several 384 
methods have been proposed for the simultaneous analysis of a large series of pharmaceuticals and 385 
drugs with LC-MS/MS with triple-quadrupole instruments. Hegstad et al. developed a multiclass 386 
LC-MS/MS method to screen several drugs of abuse on 20 mg of hair, which included 7-387 
aminonitrazepam, 7-aminoclonazepam, 7-aminoflunitrazepam, oxazepam, diazepam, alprazolam, 388 
and two benzodiazepines-like z-drugs (zopiclone and zolpidem) (Hegstad et al., 2008). Similarly, 389 
Irving and Dickson described an LC-MS/MS procedure to detect sedatives in hair and nail samples 390 
(Irving & Dickson, 2007). Nine benzodiazepines, three metabolites, and zopiclone and its 391 
metabolite were selected and detected at low level in 50 mg specimen, with LODs that ranged from 392 
0.02 pg/mg for zopiclone to 6.00 pg/mg for temazepam. This procedure was applied to the analysis 393 
of a hair sample collected 17 months after the occurrence of a DFSA: zopiclone and its metabolite 394 
were both detected in different hair segments at concentrations below 7 pg/mg (Irving and Dickson, 395 
2007). Our group developed an LC-MS/MS method to detect 14 pharmaceuticals, including 10 396 
benzodiazepines, ketamine, scopolamine, zopiclone, and zolpidem with LODs that ranged from 0.2 397 
pg/mg for ketamine and zolpidem to 4.0 pg/mg for flunitrazepam (Salomone et al., 2012a). The 398 
method was applied to a real case of segmental analysis of the hair from two women, and showed 399 
conclusive discrimination between occasional and therapeutic administration (Salomone et al., 400 
2012a). An interesting study of high-resolution segmental analysis on single hairs was developed to 401 
investigate the history of a multiple poisoning case with clozapine (Thieme & Sachs, 2012). From 402 
1-2.5 mm segments of a single hair, a highly-specific LC-MS/MS procedure allowed to detect as 403 
little as 30 fg (1 pg/mg) of clozapine and its metabolite norclozapine. The collection of hair samples 404 
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after a 165 days interval, combined with the subsequent comparison of drug concentration profiles, 405 
provided an accurate estimation of hair growth rate for the selected individuals (Thieme & Sachs, 406 
2012). 407 
Another LC-MS/MS method was proposed and validated (Xiang et al., 2011) for the 408 
quantitative determination of 18 benzodiazepines in 20 mg of hair. LODs ranged from 0.2 pg/mg 409 
for estazolam to 5 pg/mg for 7-aminoclonazepam, 7-aminonitrazepam, α-hydroxytriazolam, and α-410 
hydroxymidazolam. This method determined the distribution of estazolam after single dose intake 411 
in hair segments of healthy volunteers: estazolam concentrations ranged between 0.56 pg/mg and 412 
2.60 pg/mg. Two real cases were studied with the same method, where the victims of DFCs were 413 
exposed to clonazepam: the presence of this drug was found in several hair segments from victim 414 
#1, and ranged from 1.63 pg/mg to 15.47 pg/mg, and in two segments from victim #2 at 1.31 pg/mg 415 
and 11.93 pg/mg concentrations. The metabolite 7-aminoclonazepam was found in hair segments at 416 
considerably higher concentrations than the parent drug to demonstrate the opportunity to include 417 
also the main metabolites in the benzodiazepine-screening procedure (Xiang et al., 2011). Similarly, 418 
Kim et al. established and validated an analytical method to simultaneously detect 27 419 
benzodiazepines and metabolites plus zolpidem in hair with LC-MS/MS (Kim et al., 2011). The 420 
absolute LODs ranged from 0.005 ng (zolpidem) to 0.5 ng (bromazepam and chlordiazepoxide). 421 
The protocol was successfully applied to five forensic cases of either DFCs or benzodiazepines 422 
abuse, together with a study on drug incorporation into the hair of rats. As model for human hair, it 423 
was proved that rat-hair pigmentation does not have any significant effect on the degree of 424 
benzodiazepines (and metabolites) deposition in hair. As a matter of fact, the incorporation rates of 425 
other classes of drugs proved to depend on the hair pigmentation, to create ethnic discrimination 426 
(Gambelunghe et al., 2007; Polettini et al. 2012). The panel of screened compounds was expanded 427 
further by Lendoiro et al., who recently presented a target multi-analyte LC-ESI-MS/MS screening 428 
method to detect 35 licit and illicit drugs, including THC, in 50 mg hair samples (Lendoiro et al., 429 
2012). Among the screened substances, zolpidem, zopiclone, and 12 benzodiazepines were detected 430 
at LODs that ranged from 2 pg/mg (7-aminoflunitrazepam, flunitrazepam, lorazepam, 431 
lormetazepam, nordiazepam, and diazepam) to 10 pg/mg (oxazepam, clonazepam, and tetrazepam). 432 
Analysis of seventeen hair specimens from various forensic cases demonstrated the method 433 
applicability: several illicit and prescription drugs were tentatively identified, and subsequently 434 
confirmed with two SRM transitions in place of one (Lendoiro et al., 2012). In all the cited LC-435 
MS/MS procedures, triple-quadrupole instruments were used, and proved the efficiency of this 436 
instrument for wide multi-analyte screening. Similar LC-MS/MS configuration was also used in 437 
confirmation methods specifically designed to determine acepromazine (Gaulier et al., 2008), 438 
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diazepam, nordiazepam and tetrazepam (Laloup et al., 2007), sildenafil (Kintz et al., 2009), and 439 
gamma-hydroxybutyrate (Stout et al., 2010) in hair samples, with the purpose to investigate DFSA 440 
cases. 441 
 442 
2. High-resolution mass spectrometers 443 
 444 
Mass spectrometers other than triple quadrupoles were used for wide-range screening and 445 
confirmation analysis. Mass analyzers with high-resolution capability and accurate mass detection, 446 
such as TOF-MS and FTICR-MS, are particularly suited for a-posteriori reevaluation of the 447 
presence of drugs not considered in a preliminary target analysis. UHPLC-TOF-MS and UHPLC-448 
MS/MS were both used in the development of a specifically validated confirmation protocol, aimed 449 
to quantification of triazolam in an emblematic case of DFC (Stybe Johansen and Dahl-Sørensen, 450 
2012). In the hair segments (2 cm) that corresponded to the period of the alleged assaults, the 451 
presence of triazolam was revealed at a concentration of 1.0 pg/mg. A wider range of analytes was 452 
covered in a high-resolution mass spectrometric (HRMS) drug screening with TOF-MS (Pelander et 453 
al., 2008). The authors initially developed an analytical strategy for the comprehensive screening of 454 
drugs and doping agents in urine, but afterward the applicability of the method to other matrices, 455 
such as keratin, was also studied. Although the potential of the LC-TOF-MS approach to obtain a 456 
comprehensive drug screening in the hair of drug addicts was clearly proved, the study did not 457 
clarify whether the method sensitivity was high enough to detect drug traces from single intake. A 458 
UHPLC-TOF-MS screening procedure previously cited (Nielsen et al., 2010) targeted 52 analytes, 459 
among which 13 benzodiazepines and metabolites plus zaleplon, zolpidem, and zopiclone. For the 460 
screened molecules, homogeneous LODs were obtained that ranged from 10 pg/mg for diazepam 461 
and zolpidem, to 40 pg/mg for 7-aminoflunitrazepam and lorazepam. The method was applied to 15 462 
autopsy hair samples. In most strands, several benzodiazepines were identified. Although accurate-463 
mass analysis provided comparable selectivity to multiple SRM transitions from a triple-quadrupole 464 
instrument, the authors recommended positive findings to be confirmed with an additional method 465 
(Nielsen et al., 2010). 466 
Orbitrap technology was also used for HRMS multi-target screening of hair samples (Vogliardi 467 
et al., 2011). The purpose of this study was to develop and validate a specific method based on LC-468 
HRMS for the simultaneous detection in 50 mg hair strands of 28 benzodiazepines (and 469 
metabolites) registered in the Italian market. The "z-drugs" were not included, despite the fact that 470 
zolpidem is significantly prescribed among the Italian population. The use of a hybrid linear ion 471 
trap-Orbitrap mass spectrometer yielded LODs from 0.5 pg/mg (clotiazepam) to 10 pg/mg 472 
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(delorazepam). The validated procedure was applied to hair samples from suspected benzodiazepine 473 
consumers and showed its suitability for screening and identification of the target compounds. 474 
Indeed, the potential of such an instrument includes full-scan exact-mass measurement of 475 
protonated molecule ions and CID fragment ions, isotopic pattern recognition, and ion ratio 476 
determination between molecular and fragment ions. Recently, the same group developed and 477 
validated an analogous method to detect 28 substances that belonged to several drug classes: 478 
cocaine, amphetamines, opioids, benzodiazepines, antidepressant, and hallucinogens. Although a 479 
mass spectrometric approach similar to the one previously described was applied, a new and faster 480 
extraction process on micropulverized hair allowed reliable identification and quantification of the 481 
target drugs on as little as 2.5 mg of hair samples (Favretto et al., 2012). The combined use of full-482 
scan HRMS and CID offered the possibility of retrospective analysis to detect previously untargeted 483 
substances. 484 
 485 
D. Biomarkers for Alcohol Abuse 486 
An important goal of forensic toxicology and clinical medicine is to identify appropriate 487 
biological markers of ethanol consumption to evaluate harmful drinking and to ascertain alcohol 488 
abstinence (Pragst & Balikova, 2006). The determination of direct ethanol metabolites, such as 489 
ethyl glucuronide (EtG), ethyl sulfate (EtS), fatty acid ethyl esters (FAEEs), and 490 
phosphatidylethanol (PEth), in different biological matrices currently represents the most-valid 491 
strategy to provide unbiased evidence of chronic alcohol abuse. Among direct biomarkers, FAEEs 492 
and EtG can be detected in a variety of matrices, including hair (Pragst & Balikova, 2006), and 493 
allow one to gain information on alcohol consumption for several months. Hair analysis proved 494 
very useful to monitor ethanol use/abstinence, workplace testing, driving license reissue/renewal, 495 
child custody, divorce proceeding, withdrawal treatment (Politi et al., 2006), and post-mortem or 496 
pre-natal alcohol exposure investigation (Bendroth et al., 2008; Pragst & Yegles, 2008), even if the 497 
straightforward interpretation of analytical results has been fiercely questioned and warning about 498 
possible intra- and inter-individual variability has been raised (Tagliaro et al., 2011). 499 
According to the Society of Hair Testing, analysis of the proximal 3 cm hair segment is 500 
recommended in order to avoid partial loss of the analytes. The suggested cut-off values that 501 
support a diagnosis of chronic excessive alcohol consumption are 30 pg EtG/mg scalp hair, and 0.5 502 
ng FAEEs/mg scalp hair, respectively; both measured in the 0-3 cm proximal segment (Kintz, 503 
2012b). Figure 3 shows the effectiveness of the 30 pg EtG/mg cut-off value (horizontal line) to 504 
discriminate harmful drinkers (red dots) from low-risk drinkers and non-drinkers (yellow and green 505 
dots), whereas the cut-off value (vertical line) commonly adopted for an esteemed indirect 506 
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biomarker, such as carbohydrate-deficient transferrin (CDT), proved to have reasonable specificity 507 
but largely insufficient sensitivity, that led to about 50% false negative results (Pirro et al., 2011a). 508 
In contrast to other forensic applications, a very small number of direct alcohol biomarkers 509 
represent for toxicologists the target analytes in hair samples, essentially FAEEs and EtG. 510 
Consequently, considerable effort has been devoted to their extraction procedures and instrumental 511 
arrangements, in order to obtain continuously improving analytical performances and, above all, 512 
minimal LOD and LOQ values. In particular, the refinement of existing methods was addressed to 513 
(i) increase the laboratory throughput, with a reduction of sample preparation steps, analysis-time, 514 
and costs, (ii) increase the sensitivity and detection capability, so as to accurately quantify minute 515 
biomarkers hair concentrations (in the pg/mg range), especially to ascertain alcohol abstinence, (iii) 516 
improve the method validation protocols in order to consider all potential sources of bias and 517 
uncertainty and assure highly reliable analytical results. Under such circumstances, quite traditional 518 
instrumentations, such as triple-quadrupole mass spectrometers in the SRM mode, combined with 519 
either GC or HPLC, were almost uniquely utilized, because they assure sensitive and accurate 520 
quantification of few pre-determined target analytes. 521 
 522 
1. FAEE determination in hair samples 523 
 524 
Due to the relatively high volatility and hydrophobicity of FAEEs, HS-SPME-GC/MS is the 525 
suggested method-of-choice for the routine determination of ethyl myristate (E14), ethyl palmitate 526 
(E16), ethyl stearate (E18), and ethyl oleate (E18:1) in hair extracts (Kintz, 2012b). Among over 20 527 
ethyl esters detected in hair, these four selected analytes were found to best reflect harmful drinking 528 
(Pragst et al., 2001). In brief, deuterated internal standards are added to decontaminated hair 529 
samples, and subsequently extracted overnight with a heptane-dimethylsulfoxide mixture. The 530 
hydrocarbon layer is evaporated and the residue dissolved into a phosphate buffer, on which HS-531 
SPME is executed. The SPME fiber is analyzed with GC/MS in the electron impact (EI) ionization 532 
mode under SIM conditions. 533 
Over time, laboratories interested in testing for FAEEs adopted the protocol (Pragst et al., 534 
2001), with small changes for in-house revalidation of the method and to optimize the experimental 535 
conditions, to determine E14, E16, E18 and E18:1, with the purpose to better clarify the reliability, 536 
limitations, and potential of FAEE biomarkers in hair to ascertain harmful drinking. Later, Pragst 537 
and Yegles presented an updated procedure, with detection limits ranging between 0.003-0.01 538 
ng/mg, as determined on 30 mg of hair (Pragst & Yegles, 2008). 539 
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Kulaga et al. investigated the potential effect of hair pigmentation on FAEEs incorporation into 540 
the keratin matrix, and used, for the first time, hair collected from rats as a model matrix for FAEE 541 
production and hair inclusion (Kulaga et al., 2009). As expected for neutral and lipophilic 542 
molecules such as FAEEs, they concluded that FAEE concentration in hair does not depend on hair 543 
pigment. However, they noted that FAEE hair concentration in rats was much lower than that 544 
typically observed in humans, at comparable dosage, but still measurable with the analytical 545 
protocol adopted. Gareri et al. used the same analytical method to study the potential bias from use 546 
of ethanol-containing hair-care products on FAEE concentration measured on hair of a non-547 
compliant female population (Gareri et al., 2011). From the comparison of FAEE and EtG 548 
concentrations in the same hair samples, they concluded that use of hair-care products that contain 549 
ethanol (even at low percentage; i.e., less than 10% by volume) might affect FAEE levels in real 550 
hair samples, with experimental values from approximately 0.5 to 5.0 ng/mg, to possibly produce 551 
false non-compliant outcomes (Gareri et al., 2011). Süsse et al. considered the experimental results 552 
from as many as 1872 hair samples from forensic cases (Süsse et al., 2012). They deduced that (i) 553 
the use of hair spray might affect (increase) detected FAEEs, but not EtG, hair concentrations; (ii) 554 
conversely, bleaching and dying hair treatments might affect (decrease) EtG, but not FAEEs, hair 555 
concentrations, whereas (iii) hair gel, hair wax, oil, and grease have apparently no influence on 556 
FAEEs and EtG. 557 
Süsse et al. reported a method with detection limits ranging from 0.008 to 0.026 ng/mg, as 558 
measured on 20-50 mg hair samples (Süsse et al., 2010). These analytical features allowed the same 559 
authors to accurately measure the basic levels of hair FAEEs in strict teetotalers: the results showed 560 
that 20% of abstainers (N=242) presented total a FAEE concentration that exceeded the cut-off 561 
values of 0.5 or 1.0 ng/mg, as a function of the examined hair length (Süsse et al., 2012). In 562 
contrast, Albermann et al. reported total a FAEEs concentration lower than 0.2 ng/mg for 74% of 563 
drivers who self-claim as abstinent (N=160), whereas only 9% of these samples showed a FAEE 564 
concentration that exceeded 0.5 ng/mg, among which some true-positive cases (Albermann et al., 565 
2011). 566 
Lately, Hastedt et al. updated and revalidated the HS-SPME-GC/MS method originally 567 
developed by Pragst et al. (Hastedt et al., 2012; Pragst et al., 2001). Better detection limits were 568 
achieved (0.004-0.014 ng/mg), although an expanded time to complete the chromatography cycle 569 
was needed (over 30 min) than in the original method. 570 
On the other hand, Caprara et al. and Kulaga et al. described a different analytical strategy to 571 
quantify a larger number of FAEEs in neonatal human and animal hair samples, with ethyl 572 
heptadecanoate as the internal standard (Caprara et al., 2006; Kulaga et al., 2006). They adopted 573 
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solid-phase extraction (SPE) in place of SPME to isolate FAEEs from hair extracts, followed with 574 
either GC/MS or GC/MS/MS in the chemical ionization (CI) mode, with isobutene as the ionizing 575 
gas. Unlike EI, which typically leads to an extensive, but nearly identical, fragmentation patterns for 576 
all FAEEs, CI virtually generates only the protonated molecule ion, which is distinctive for each 577 
ethyl ester. MS/MS performed in an ion-trap device clearly adds specificity to the method. In 578 
choosing CI rather than EI for the analysis, good detection limits were achieved (<2.4-6.6 pg/mg), 579 
only recently outperformed, as reported above. FAEE-analysis profile was also expanded to six, 580 
rather than four esters, by adding ethyl laureate (E12), and ethyl palmitoleate (E16:1), and 581 
cumulative analysis of all commonly occurring FAEEs in biological matrices was suggested to 582 
provide a more effective way to identify neonates with suspected pre-natal exposure to ethanol 583 
(Caprara et al., 2006; Kulaga et al., 2006). 584 
By taking advantage of the preceding experiences, Zimmermann and Jackson proposed a 585 
globally revisited analytical method to determine five FAEEs (E12, E14, E16, E18, and E18:1) in 586 
human hair, and aimed to combine high sample throughput with analytical performances 587 
(Zimmermann & Jackson, 2010). Instead of extensive washing procedures and an overnight 588 
extraction, followed by a 20 or 40 min-long GC/MS analysis, they proposed a method that required 589 
a total analysis-time of less than 1 hour, including a 15-minute sonication-extraction procedure, 590 
followed with HS-SPME-GC/MS/MS, performed with a quadrupole ion trap. Positive-CI combined 591 
with MS/MS provided high selectivity and detection capability, despite a total chromatography 592 
cycle time of only 9 min. The limits of detection ranged from 0.002 to 0.030 ng/mg (Zimmermann 593 
& Jackson, 2010). More recently, Politi et al. developed a sensitive (LOQ = 0.01 ng/mg for each 594 
FAEE) analytical protocol for FAEE determination in hair, based on the widespread SPE and GC-595 
EI-MS techniques (Politi et al., 2011). These techniques are affordable by any toxicology laboratory 596 
- a key feature to make this determination routine. Four ethyl esters (E14, E16, E18, and E18:1) 597 
were chromatographically separated in about 16 min. Faster chromatographic analysis is prevented 598 
by the need to obtain well-separated peaks and no interferences, because FAEEs share most EI 599 
fragment ion signals. 600 
 601 
2. EtG determination in hair samples 602 
 603 
EtG is a polar substance with a relatively low molecular weight. Due to these attributes, a single-604 
stage of MS analysis is generally insufficient to comply with the low detection limits in the pg/mg 605 
range required for its determination in a complex keratinic matrix. Either GC/MS/MS after 606 
derivatization or LC-MS/MS are the methods of choice for EtG determination in hair samples; both 607 
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are capable to minimize the background interferences and to achieve the optimal detection 608 
capability and high specificity, required in toxicological and forensic applications. The limitations 609 
of the simple GC-EI-MS approach for EtG determination in hair samples is indirectly demonstrated 610 
by a recently developed method, which barely reaches an LOD of 100 pg/mg with as much as 100 611 
mg of hair in the SIM acquisition mode (Álvarez et al., 2009). This LOD value is considerably 612 
higher than the established cut-off limit to evidence alcohol use disorders (Kintz, 2012b). 613 
Although the simplicity and progressively increasing performances of ESI make the LC-MS/MS 614 
approach prevalent nowadays, several highly-efficient GC/MS/MS methods have been recently 615 
developed and updated to fulfill the legal requisites entailed by regulations of many countries. Paul 616 
et al. proposed and validated a GC/MS/MS procedure, with EI, triple-quadrupole mass 617 
spectrometer, and SRM (Paul et al., 2008). The instrumental analysis followed water extraction, 618 
SPE purification, and derivatization with N,O-bis[trimethylsilyl]trifluoroacetamide (BSTFA). An 619 
LOD of 5 pg/mg was obtained, and the chromatography cycle was 7.30 min (Paul et al., 2008). A 620 
modified protocol was reported by the same group in 2011, in which the SRM transitions for GHB 621 
were added to the same analytical protocol, so as to detect EtG and GHB within a single 622 
chromatographic procedure. This combination is of importance in the investigation of drug-623 
facilitated crimes, because GHB and alcohol are frequently combined substances used to perpetrate 624 
these offences (Paul et al., 2011). 625 
Large-volume injection (LVI) GC-EI-MS/MS was proposed to increase the sensitivity in hair 626 
EtG determination. The authors suggested that, upon optimization of streaming volume, purge time, 627 
programmable temperature vaporization (PTV) temperature, injection volume, and other 628 
experimental parameters, the detection capability can be improved by at least 1–2 orders of 629 
magnitude, as compared to the traditional approach (Shi et al., 2010). Even so, they estimated an 630 
LOD value of 5 pg/mg, with 20 mg of hair, as in the method previously cited (Paul et al., 2008). 631 
NCI with methane was proposed as an alternative to EI within a GC/MS/MS protocol in order 632 
to improve analytical sensitivity (Kharbouche et al., 2009). A high cross-section for electron capture 633 
was induced by double derivatization of EtG with perfluoropentanoic anhydride. The choice of two 634 
selective SRM transitions allowed high specificity in the analyte identification, despite the fast GC 635 
protocol. The estimated LOD value for EtG was 3 pg/mg, with 30 mg hair. This analytical protocol 636 
was adopted to analyze rat hair samples, so as to evaluate any potential hair-pigmentation effect on 637 
EtG incorporation into the keratin matrix. No statistically significant differences were observed 638 
between pigmented and non-pigmented hair (Kharbouche et al., 2010). The same group also 639 
evaluated the possible effect of hair-care products on EtG incorporation (Sporkert et al., 2012). 640 
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A similar GC-NCI-MS/MS approach was also proposed (Agius et al., 2010), but the final EtG 641 
enrichment was performed with HS-SPME, after derivatization with heptafluorobutyric anhydride. 642 
HS-SPME injection yielded further clean-up in the headspace extraction and accumulation of the 643 
derivatized analyte on the fiber, with a significant decrease of the LOD value: 0.6 pg/mg, with 10 644 
mg hair (Agius et al., 2010). No further improvements were recorded with nonafluorobutyrric 645 
anhydride for EtG derivatization instead of heptafluorobutyric anhydride. A similar LOD value (0.7 646 
pg/mg) was also achieved (Kerekes et al., 2009), from 20-30 mg of hair, although NCI was 647 
followed by single MS detection, with two monitored ions in the SIM acquisition mode. The EtG 648 
concentration was in hair collected from several parts of the body for the same subjects determined 649 
and compared (Kerekes et al., 2009). 650 
Even though the GC/MS/MS procedures for EtG determination in hair proved to be accurate and 651 
highly sensitive, especially when electron capture was used, most toxicology laboratories currently 652 
prefer LC-MS/MS, because the sample-purification steps are easier and no derivatization is needed. 653 
These simplifications substantially contribute to reduce the work and time for sample processing - a 654 
crucial aspect in laboratories with high sample load. 655 
Although the first LC-MS/MS method dates back to 2002, the real bloom of analytical 656 
procedures based on LC separation and ESI started in 2007. ESI is commonly used in the negative 657 
ion mode because of the acidic nature of EtG. Among the large variety of proposed methods, 658 
different sample-preparation steps, amounts of analyzed hair, and chromatographic conditions were 659 
adopted that yielded excellent selectivity and LOD values between 1 and 10 pg/mg. The proposed 660 
methods proved highly reliable to support evaluation of harmful drinking (Morini et al., 2009; 661 
Marques et al., 2010; Pirro et al., 2011a; Agius et al., 2012); monitor total abstinence (Kronstrand et 662 
al., 2012); study hair-treatment effects that possibly lead to partial disappearance of EtG from the 663 
keratin matrix (Morini et al., 2010); and evaluate the effect of individual and external parameters on 664 
EtG accumulation and persistence in hair, so as to define the boundaries and to exclude conditions 665 
for its use as a biomarker of ethanol consumption (Pragst et al., 2010, Süsse et al., 2012; Hastedt et 666 
al., 2012; Cabarcos et al., 2012; Pirro et al., 2011b). Almost all these methods made use of triple-667 
quadrupole instruments to monitor SRM transitions between the deprotonated molecule ion of EtG 668 
(m/z 221) and two fragment ions (m/z 75, 85). For EtG determination in hair samples, a detailed list 669 
of MS conditions used in the cited articles is presented in Table 1. Conditions for GC and LC 670 
methods are reported. 671 
The major critical point of hair EtG determination with LC-ESI-MS/MS methods is the possible 672 
occurrence of matrix effects (Matuszewski et al., 2003; Peters & Remane, 2012), especially when a 673 
non-polar stationary phase is used for LC separation; i.e., EtG eluted quickly. In any case, matrix 674 
 22
effects need to be carefully evaluated during method development and validation (Lamoureux et al., 675 
2009; Tarcumnicu et al., 2010; Cabarcos et al., 2012). Several authors proposed to modify 676 
previously developed analytical protocols in order to improve sample clean-up (essentially with 677 
SPE) and consequently reduce ion-suppression and increase the signal-to-noise ratio. Politi et al. 678 
reported an extreme case, in which SPE clean-up proved useful to decrease ion suppression and 679 
identify EtG traces in three hair segments of a known alcoholic, 27 years after his death (Politi et 680 
al., 2008). 681 
Carbon-blend SPE columns, based on porous graphitic material, are suitable for the extraction 682 
of EtG from complex matrices such as hair (Lamoureux et al., 2009). Besides, the use of silica 683 
HPLC columns, in place of reversed-phase columns, allows one to elute EtG with a mobile phase 684 
that contain a high percentage of organic solvent and low percentage of water, to improve ESI 685 
efficiency (Lamoureux et al., 2009). An alternative strategy, proposed previously, made use of post-686 
column addition of acetonitrile to the eluate. For the same goal, the use of HILIC coupled to mass 687 
spectrometry was proposed and successfully applied for the analysis of EtG in hair (Kintz et al., 688 
2008; Tarcumnicu et al., 2010). Recently, Albermann et al. proposed a modification of their method 689 
for EtG determination in hair, aimed to solve occasional chromatographic problems during routine 690 
work (Albermann et al., 2012). The new method used an LC column with stationary phase 691 
composed of 100% porous graphitic carbon, instead of the reversed-phase LC column previously 692 
used (Albermann et al., 2010). However, the new method led to a longer analysis-time and slightly 693 
higher LOD value (1.7 pg/mg) than previously reported (1 pg/mg). 694 
 695 
E. Antidoping Analysis 696 
In amateur and professional sport, the artificial enhancement of the athletic performance with drugs 697 
or forbidden practices is subjected to systematic control. Doping controls in sport events are 698 
managed by the World Anti-Doping Agency (WADA), through tests of urine or blood sample 699 
collected from athletes in and out of competition. Hair analysis is currently not accepted as an 700 
alternative to urine and blood analysis for doping control (WADA, 2012) for several reasons, 701 
including its heterogeneous nature, the uncertainty on mechanisms that regulate drug incorporation, 702 
and alleged diversity in occurrence and extent of these mechanisms among different ethnic groups 703 
(Kintz, 2007a). However, it is evident that hair analysis would be of practical significance in several 704 
circumstances, because it provides complementary information with respect to urine and blood 705 
testing (Gaillard et al., 2000; Kintz, 2003). In fact, urine and blood analyses detect recent drug 706 
intake, but cannot distinguish between chronic use or single exposure, whereas hair analysis can 707 
offer this distinction (Kintz, 2007a). Indeed, doping agents are partially excreted in the sweat and 708 
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incorporated into growing hair, and remain stable for long periods of time. Thus, hair testing might 709 
offer a large detection window to allow long-term detection of prohibited drugs and a retrospective 710 
estimation of the intake period. This opportunity appears to be particularly important to detect out-711 
of-competition doping treatments; for example, in the athletes who use anabolic substances during 712 
the training period and interrupt their intake long before the start of competition (Kintz et al., 2000). 713 
The need for equal conditions for all athletes and the freedom for them to make use of whatever 714 
cosmetic treatment, including complete body shaving, prevented any official use of hair analysis in 715 
doping controls. For example, the incorporation rates of prohibited drugs was proved to depend on 716 
the hair pigmentation, to possibly lead to unequal conditions in doping control, and consequently 717 
ethnic discrimination (Gambelunghe et al., 2007). In addition, hair washing, discoloring, and tinting 718 
appear to influence the drug concentration measured in hair, as well as their distribution within the 719 
hair longitudinal axis (Kintz, 2003). Nevertheless, the potential of hair analysis for antidoping 720 
purposes is so strong that several analytical methods were developed in the past to detect doping 721 
agents in hair specimens (Kintz, 2007a). 722 
In the last five years, a limited number of analytical methods was additionally developed, with 723 
the main objective to measure anabolic androgenic steroid (AASs) level in human hair with gas or 724 
liquid chromatography coupled to high-resolution mass spectrometry or tandem mass spectrometry 725 
(Anielski, 2008; Gambelunghe et al., 2007; Deshmukh et al., 2010). A complex challenge was 726 
addressed to exploit hair analysis to distinguish between natural production of endogenous steroids 727 
(e.g., testosterone) and exogenous uptake of the same steroids (Shen et al, 2009; Pozo et al, 2009, 728 
Deshmukh et al. 2012). AASs represent the most frequently detected class of substances in out-of-729 
competition doping testing, because they are widely abused to increase strength and lean body 730 
mass, and also lead to reduced recovery periods (Thieme et al., 2000; Pozo et al., 2009; Deshmukh 731 
et al. 2010). AASs are also utilized to speed up muscle growth in cattle and horses (Gaillard et al., 732 
1999; Anielski, 2008). AAS detection in hair specimens is more widely accepted in animals than in 733 
humans; it still receives a considerable interest in the scientific research, as demonstrated recently 734 
(Nielen et al., 2011) in which hormone and veterinary drug screening and, in general, forensic 735 
investigations can benefit from the recent developments in desorption electrospray ionization 736 
(DESI) mass spectrometry (Takáts et al., 2004). DESI allowed bovine hair analysis with very 737 
limited sample preparation: after rapid ultrasonic liquid extraction, a few microliters of supernatant 738 
were deposited onto a glass or PTFE surface, and dried, before DESI analysis. Full-scan and MS3 739 
experiments with a linear ion trap MS were used to detect estradiol benzoate, testosterone 740 
cypionate, and testosterone decanoate to demonstrate the general feasibility of rapid screening and 741 
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detection of anabolic steroid intact esters. Quite high levels (300–800 g/kg) of steroid esters are 742 
generally present in hair samples from controlled and illegally treated animals (Nielen et al., 2011). 743 
Anielski published a method to detect anabolic steroids and their esters in hair material 744 
(Anielski, 2008). After hair extraction (sonication, methanol, 4h, 50°C) and LLE raw purification, a 745 
refined sample clean-up procedure was carried out with HPLC. The residue was subsequently 746 
derivatized, and the trialkylsilyl steroid derivatives were analyzed with GC/HRMS and GC/MS/MS 747 
to yield LOD values between 0.1 and 5.0 pg/mg. The method was successfully applied to real 748 
samples to detect testosterone propionate in the hair of treated horses. Unlike a urine specimen, the 749 
parent drugs instead of their metabolites are more frequently detected in hair samples. 750 
The goal to determine the natural occurrence of anabolic steroids in hair, and their biological 751 
variability within selected populations of individuals, led Shen et al. to develop a specific 752 
GC/MS/MS method to simultaneously identify testosterone, epitestosterone, androsterone, 753 
etiocholanolone, and dehydroepiandrosterone (DHEA) (Shen et al., 2009). After alkaline digestion 754 
(NaOH, 1N, 10 min, 90°C), LLE extraction with diethylether was carried out. The extracts were 755 
derivatized with a MSTFA/iodotrimethylsilane/dithioerythritol mixture (10:5:5, v/v/w) and 756 
analyzed with GC/MS/MS/SRM. The method was fully validated and applied to 80 subjects (39 757 
males, 30 females, 11 children). The sensitivity of the method (LODs between 0.1 and 0.2 ng/mg) 758 
proved sufficient to determine the physiological concentration ranges for the selected endogenous 759 
steroids in the three populations, so as to address the interpretation of non-compliant results from 760 
alleged steroid abuse (Shen et al., 2009). 761 
An analogous GC/MS/MS method was previously developed for the simultaneous 762 
determination of methyltestosterone, nandrolone, boldenone, fluoxymesterone, cocaine, and 763 
benzoylecgonine, and was applied to hair samples from seven athletes with reported AAS abuse 764 
(Gambelunghe et al., 2007). All anabolic steroids included in the procedure could be detected with a 765 
10 pg/mg detection limit. Methyltestosterone, nandrolone, boldenone, and fluoxymesterone were 766 
detected in real samples between 12 pg/mg and 37 pg/mg. 767 
A specific LC-MS/MS method was developed for the clinical determination of testosterone 768 
undecanoate in hair samples (Pozo et al., 2009). After decontamination and incubation in a tris(2-769 
carboxyethyl)phosphine hydrochloride solution (1.5h, 50°C) within an ultrasonic bath, a double 770 
LLE with n-pentane was performed. The reconstituted residue was injected into an LC-MS/MS 771 
triple-quadrupole mass spectrometer with APCI source. The proposed fragmentation pattern of 772 
testosterone undecanoate is shown in Figure 4. The method was applied to hair samples from three 773 
patients treated with testosterone undecanoate and led to detected concentrations of 0.4, 1.6 and 8.4 774 
pg/mg. 775 
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The group of Naughton and coworkers recently published two sensitive LC-MS/MS methods 776 
for the detection of various steroids in human hair samples. In the first study, nandrolone and 777 
stanozolol were determined in human hair for the first time (Deshmukh et al., 2010). After alkaline 778 
digestion (NaOH, 1M, 15 min, 95°C) and LLE with n-pentane, the extracts were injected into a 779 
UHPLC system interfaced to a triple-quadrupole mass spectrometer with ESI source. From 20 mg 780 
aliquots of hair, LOD values of 0.5 pg/mg for stanozolol and 3.0 pg/mg for nandrolone were 781 
obtained. The method was successfully applied to 19 hair samples previously tested positive with 782 
ELISA (enzyme-linked immunosorbent assay) screening to reveal seven false-positive results and 783 
to confirm one sample positive to nandrolone (14.0 pg/mg) and eleven samples positive to 784 
stanozolol (concentration range 5.0÷86.3 pg/mg). The second study used a similar experimental 785 
approach to develop a highly sensitive LC-MS/MS method to determine testosterone and 786 
epitestosterone in hair samples (Deshmukh et al., 2012). The natural abundance ratio of these 787 
steroids (T/E) is significantly modified by any exogenous intake of testosterone. Low LOD values 788 
(0.1 pg/mg and 0.25 pg/mg for testosterone and epitestosterone, respectively, from 50 mg of hair) 789 
allowed the determination of physiological testosterone and epitestosterone levels on 75 real 790 
samples, which ranged from 0.70 to 11.81 pg/mg in males and 0.33 to 6.05 pg/mg in females 791 
(testosterone); from 0.63 to 8.27 pg/mg in males and 0.52 to 3.88 pg/mg in females 792 
(epitestosterone). 793 
 794 
III. FUTURE TRENDS OF HAIR ANALYSIS 795 
 796 
A. New Designer Drugs 797 
In the last years, forensic laboratories have been challenged worldwide with the puzzle to detect 798 
a variety of new psychoactive substances. These compounds, occasionally called either designer 799 
drugs or legal highs, have little or no previous history of medicinal use. Amphetamine derivatives, 800 
with backbone molecular structures of piperazine and cathinone, initially represented the main 801 
group of designer drugs. Almost at the same time, another wide group of compounds, known as 802 
synthetic cannabinoids, appeared on the black market. A very rapid proliferation of new 803 
psychoactive substances of these and other classes followed in recent years. Although most of the 804 
latest drugs act as central nervous system (CNS) stimulants, their assorted chemical structures range 805 
from derivatives of pipradrol, ketamine, phencyclidine, arecoline, aminopropylbenzofuran, ring-806 
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substituted aminoindans, thiophenyl bioisosteres of methamphetamine, as well as compounds 807 
structurally related to cocaine (King & Kicman, 2011). 808 
Reference standards for most designer-drugs metabolites are not yet commercially available. 809 
That lack of standards poses a serious and longstanding challenge to toxicological laboratories to 810 
develop analytical procedures to detect their presence in a variety of biological matrices. 811 
Nevertheless, several analytical methods were developed to determine some of these new 812 
psychoactive substances and/or their metabolites in either blood or urine (Moran et al., 2011; 813 
Grigoryev et al., 2011; Dresen et al., 2011; Teske et al., 2010; Wintermeyer et al., 2010; Beuck et 814 
al., 2011; Kraemer et al., 2009; Sobolevsky, Prasolov, & Rodchenkov, 2010). On the other hand, 815 
only very few studies have been published to date that describe protocols for the detection of these 816 
substances in hair samples. 817 
In a Letter to the Editor, Torrance and Cooper reported the detection of mephedrone in hair 818 
samples at 4.2 and 4.7 ng/mg concentration with a ISO/17025 accredited method, but details on the 819 
analytical method used and comments or interpretations of results were not included (Torrance & 820 
Cooper, 2010). A specific and accurate method for mephedrone detection with GC/MS was 821 
proposed (Martin et al., 2012). The study reported that 67 real hair samples were analyzed - 10 were 822 
found positive, with mephedrone concentrations from 0.2 to 313.2 ng/mg; 8 of them were below 6 823 
ng/mg. As for amphetamines, it is deduced that mephedrone concentrations in hair are likely in the 824 
ng/mg, not pg/mg, at least in the cases of repeated abuse (Martin et al., 2012). Detection of 825 
piperazine-like compounds was meticulously described (Barroso et al., 2010b). This study was the 826 
first to report the development and validation of an analytical method for the determination of three 827 
phenylpiperazines in hair samples. Trimethylsilyl derivatives were determined with GC/MS, and 828 
the method was applied to autoptic samples and samples collected from subjects under psychiatric 829 
evaluation. 830 
The first multiclass screening for synthetic cannabinoids in hair samples was published recently 831 
(Salomone et al., 2012b). In this study, a UHPLC-MS/MS procedure was developed and validated 832 
to determine the possible presence of five synthetic cannabinoids (i.e., consistently present in the 833 
black market during the period considered: JWH-018, JWH-073, JWH 200, JWH-250, and HU-834 
210) in 179 real hair samples collected from previously proven Cannabis consumers (Figure 5). The 835 
fourteen (7.82%) samples found positive to at least one synthetic cannabinoid demonstrated 836 
significant diffusion among drug abusers. Concentrations of synthetic cannabinoids ranged from 837 
0.50 to 730 pg/mg. Although the published screening was limited to relatively few compounds, its 838 
UHPLC-MS/MS approach makes further method expansion feasible, so as to include new 839 
substances that are continuously introduced into the black market. 840 
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 841 
B. Future Trends Driven by Instrumental Developments 842 
 843 
After years of pioneering studies, hair analysis for toxicology applications represents nowadays 844 
a reliable and well-established means of forensic investigation. The Society of Hair Testing 845 
periodically meets to exchange scientific experiences, establish new protocols, and draw up 846 
consensus documents to carefully guide conclusions and legal judgments on the basis of 847 
experimental results from hair analysis. 848 
Whereas instrumental sensitivity and overall method specificity have been for years key issues 849 
of experimental studies and analytical method developments, the latest instrumentation for sample 850 
treatment, chromatographic separation, and mass spectrometric detection substantially fulfills these 851 
requirements, and frequently provides LOD and LOQ values largely better (i.e., lower) than the 852 
expected drug concentrations in hair. Indeed, various sources of individual variability, including 853 
genetic polymorphisms, metabolic disorders, diet, use of cosmetics, and environmental exposure, 854 
are likely to represent more-important causes of bias and incorrect reporting than insufficient 855 
sensitivity and specificity. For example, the LOD for EtG in hair will soon break the 1 pg/mg limit 856 
and will open up a reflection on the possible origins of this alcohol metabolite other than ingestion 857 
of alcoholic beverages. Moreover, the chance of external contamination of hair samples and extracts 858 
grows with increasing method sensitivity, in turn becoming a major concern during the 859 
experimental method validation. 860 
Other issues, basically linked to one another, are becoming increasingly important in forensic 861 
hair analysis. These issues are: multiresidue and multiclass potential, high throughput, and costs of 862 
analysis. Capability of simultaneous multiclass analysis is essential in broad drug screening of 863 
unknown analytes, because in most acute intoxications and post-mortem investigations the ingested 864 
substance cannot be anticipated; however, this feature also contributes to dramatically decrease the 865 
number of analysis for each sample, with a resultant cost lowering. Modern UHPLC-MS/MS 866 
instruments with triple-quadrupole analyzers can already simultaneously detect more than one 867 
hundred substances in just a few minutes, and QuEChERS-like procedures to extract hair samples 868 
are rapidly spreading within toxicology laboratories. This trend will be probably pursued further in 869 
the near future, up to new limits in terms of speed and number of target analytes, so as to manage 870 
hundreds of samples per day. Automatically-driven high-resolution MS/MS instruments, 871 
sequentially generating data-dependent CID product-ion spectra, will provide true general unknown 872 
screening and will allow retrospective inquiry of previously acquired data. Improvements in mass 873 
analyzers that will lead to enhanced sensitivity and mass resolution at high scanning rate will 874 
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possibly make these instruments preferable to triple quadrupoles for general unknown screening 875 
analysis. 876 
High throughput and costs of analysis are strictly connected to one another. Hair analysis is still 877 
an expensive determination that prevents its generalized application to workplace and driving 878 
license testing, even if it is evident that drivers and, for example, workers who carry fire-arms 879 
should not be habitual drug consumers. The analysis costs are due to the labor-intensive hair-sample 880 
treatment and the difficulty to test all drugs of abuse at once. Further development of direct MS 881 
methods of analysis, such as DESI or MALDI-TOF, combined with simplified sample handling, 882 
could possibly provide very fast and cheap drug screening of hair samples in the future. Even if the 883 
sensitivity of these instrumental approaches is still low, quite high cut-off values could be accepted 884 
whenever the scope of the screening is to single out only the chronic drug consumers. Also, MS-885 
imaging techniques require significant improvement, in terms of hair sample handling and 886 
instrumental sensitivity, before generalized application can be found in the chronological 887 
assessment of drug intake. 888 
The scientific literature reports no studies on the application of isotope-ratio mass spectrometry 889 
(IRMS) to hair analysis to discriminate the natural vs. exogenic origin of substances present therein. 890 
The substances of interest might include doping agents, such as steroids, as well as a common rape 891 
drug; i.e., gamma-hydroxybutyric acid. The reasons for this lack can be found again in the limited 892 
sensitivity of the technique, the restricted sample availability, the complexity of its purification, and 893 
that specificity provided by mass selection is lost in the combustion process. The chance of using 894 
IRMS to detect the illegal administration of drugs over extended periods of time, as it might occur 895 
for androgenic steroids, will possibly push some scientific efforts in this direction in the near future. 896 
In general, the recent major improvements of MS and chromatographic instrumentation have 897 
driven forensic toxicology toward previously inconceivable results. Among these studies, it is 898 
impressive to note that hair analysis can nowadays provide evidence of a single administration of 899 
drugs. The continuous enhancement of MS sensitivity progressively reduces the amount of hair 900 
sample needed for the chemical analysis, and extends the chance to investigate newborn children, to 901 
detect pre-natal drugs exposure. The scientific goal to gain toxicological information from a single 902 
hair has already started, in a worthy competition with forensic genetics. Further unexpected 903 
developments of MS instruments are likely to have immediate impact also in the investigations of 904 





IV. ABBREVIATIONS 909 
All abbreviations and acronyms used in this article are listed in Table 2.  910 
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TABLE 1.  Comparison of MS conditions for EtG determination in hair samples 
Authors, year Analytical Technique Mass Analyzer 
m/z Ions  
(acquisition mode) Derivatization 
Álvarez et al., 2009 GC-EI-MS single quadrupole 261; 160; 405  (SIM) BSTFA 
Paul et al., 2008 
Paul et al., 2011 GC-EI-MS/MS triple quadrupole 261→ 143  (SRM) BSTFA 
Shi et al., 2010 GC-EI-MS/MS triple quadrupole 261→ 143  261→ 73 (SRM) BSTFA 
Kharbouche et al., 2009 
Kharbouche et al., 2010 
Sporkert et al., 2012 
GC-NCI-MS/MS triple quadrupole 347 → 163 347 → 119 (SRM) PFPA 
Agius et al., 2010 GC-NCI-MS/MS triple quadrupole 596 → 427 596 → 288 (SRM) HFBA 
Kerekes et al., 2009 GC-NCI-MS single quadrupole 496; 349 (SIM) PFPA 
Morini et al., 2009 
Morini et al., 2010 
Politi et al., 2008 
LC-ESI-MS/MS triple quadrupole 
221→ 221 
221 → 85 
221 → 75 
(SRM) - 
Pirro et al., 2011a 
Pirro et al., 2011b 
Kronstrand et al., 2012 
Pragst et al., 2010 
Hastedt et al., 2012 
Lamoreux et al., 2009 
Tarcumnicu et al., 2010 
Kintz et al., 2008 
LC-ESI-MS/MS triple quadrupole 221 → 85 221 → 75 (SRM) - 
Süsse et al., 2010 
Süsse et al., 2012 LC-ESI-MS/MS triple quadrupole 
221 → 75 
221 → 57 
221 → 55 
(SRM) - 
Cabarcos et al., 2012 LC-ESI-MS/MS ion trap 
221 → 203 
221 → 85 
221 → 75 
(SRM) - 
Albermann et al., 2010 
Albermann et al., 2012 LC-ESI-MS/MS triple quadrupole 
221 → 113 
221 → 85 


















 CBN Cannabinol 
 CDB Cannabidiol 
 
CDT Carbohydrate-Deficient Transferrin 
 
CI Chemical Ionization 
 
CID Collision-Induced Dissociation 
 
CNS Central Nervous System  
 
CZE Capillary Zone Electrophoresis 
 
DESI Desorption Ionization Mass Spectrometry 
 
DFC Drug Facilitated Crime 
 




E12 Ethyl laureate 
 
E14 Ethyl myristate  
 
E16 Ethyl palmitate 
 
E16:1 Ethyl palmitoleate 
 
E18 Ethyl stearate  
 
E18:1 Ethyl oleate 
 
EI Electron Impact 
 
ELISA Enzyme-Linked ImmunoSorbent Assay 
 
EME Ecgonine Methyl Ester 
 
ESI Electrospray Ionization 
 
EtG Ethyl Glucuronide 
 
EtS Ethyl Sulfate 
 
FAEE Fatty Acid Ethyl Esters 
 
FTICR Fourier Transform Ion Cyclotron Resonance 
 GC Gas Chromatography 
 
HFBA Heptafluorobutyric Anhydride 
 
HILIC Hydrophilic Interaction Liquid Chromatography 
 
HPLC High Pressure Liquid Chromatography 
 
HRMS High Resolution Mass Spectrometry 
 HS-SPME Head Space Solid-phase MicroEstraction 
 
IMS Imaging Mass Spectrometry 
 
IRMS Isotope-Ratio Mass Spectrometry 
 
LC Liquid Chromatography 
 LLE Liquid-Liquid Extraction 
 
LOD Limit of Detection 
 
LOQ Limit of Quantification 
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TABLE 2.  (Continued) 
 
LVI Large Volume Injection 
 
LTP Low Temperature Plasma 
 












MiAMi Micropulverized Extraction Aqueous Acetylation Microextraction   
 
MIP Molecularly Imprinted Polimers 
 
MISPE Molecularly Imprinted Solid-Phase MicroExtraction 
 MS Mass Spectrometry 
 








PTV Programmable Temperature Vaporization 
 
QqQ Triple quadrupole mass spectrometer 
 
QqQLIT Hybrid triple quadrupole linear ion trap mass spectrometer 
 
QuEChERS Quick Easy Cheap Effective Rugged Safe 
 
SIM Selected Ion Monitoring 
 
SOHT Society of Hair Testing 
 
SOHT Society of Hair Testing 
 
SPE Solid-phase Extraction 
 
SRM Selected Reaction Monitoring 
 THC ∆9-tetrahydrocannabinol 
 
TMCS Trimethylchlorosilane  
 
TOF Time of Flight 
 
UHPLC Ultra High Performance Liquid Chromatography 
 






FIGURE 1. MALDI-MS analytical workflow for single hair analysis. The whole process from 
sample preparation to SRM relative quantitation and MS/MS and MS3 confirmatory analyses takes 
approximately 2 h, including the analysis of multiple samples (Porta et al., 2011; reproduced with 
permission, American Chemical Society, copyright 2011).   
 
FIGURE 2. GC×GC contour plot (TIC) obtained for a hair sample. (1) Cotinine; (2) meconin; (3) 
mesocain; (4) tropacaine; 5.EDDP; (6) phenazocine; (7) hydroxycotinine-TBDMS; (8) methadone; 
(9) quaalude; (10) norcocaine; (11) cocaine; (12) cocaethylene; (13) codeine; (14) diazepam; (15) 
benzoylecgonine-TBDMS; (16) acetylcodeine; (17) cinnamoylcocaine; (18) diacetylmorphine; (19) 
codeine-TBDMS; (20) morphine-TBDMS; (21) 6-MAM-TBDMS; (22) Papaverine; (23) morphine-
di-TBDMS (Guthery et al., 2010; reproduced with permission, Elsevier, copyright 2010). 
 
FIGURE 3. Concentration of head hair EtG (pg/mg) versus %CDT for 175 patients clinically 
classified as non-drinkers (A, green dots, N=65), social drinkers (S, yellow dots, N=51), and active 
heavy drinkers (H, red dots, N=59). The data are reported on a logarithmic scale. Horizontal and 
vertical lines divide the plane into four quadrants (I-IV) that identify the number of true and false 
positive (or negative) results in each category: For heavy drinkers (red dots): I. True-positive 
results; II. false-negative results for CDT only; III. false-negative results; IV. false-negative results 
for head hair EtG only  (Pirro et al., 2011; redrawn with permission, Springer, copyright 2011). 
 
FIGURE 4. Proposed fragmentation pattern for testosterone undecanoate (Pozo et al., 2009; 
reproduced with permission, John Wiley and Sons, copyright 2009).  
 
FIGURE 5. SRM chromatogram of a blank hair sample fortified with the target compounds: (1) 
JWH-200, (2) JWH-250, (3) JWH-073, (4) CBD, (5) JWH-018, (6) CBN, (7) HU-210, (8) THC, 
(ISTD) JWH-018-d9 (Salomone et al., 2012; reproduced with permission, John Wiley and Sons, 
copyright 2012). 
 
 
 
 
 
 
 
 
 
 
 
